OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients with Malignancy
Mona Ariamanesh, Pejman Porouhan, Babak PeyroShabany, et al.
Cancer Investigation (2021) Vol. 40, Iss. 1, pp. 26-34
Open Access | Times Cited: 71
Mona Ariamanesh, Pejman Porouhan, Babak PeyroShabany, et al.
Cancer Investigation (2021) Vol. 40, Iss. 1, pp. 26-34
Open Access | Times Cited: 71
Showing 1-25 of 71 citing articles:
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
Annika Fendler, Elisabeth G.E. de Vries, Corine H. GeurtsvanKessel, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 385-401
Open Access | Times Cited: 178
Annika Fendler, Elisabeth G.E. de Vries, Corine H. GeurtsvanKessel, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 385-401
Open Access | Times Cited: 178
COVID-19 in patients with hematologic malignancy
Petra Langerbeins, Michael Hallek
Blood (2022) Vol. 140, Iss. 3, pp. 236-252
Open Access | Times Cited: 108
Petra Langerbeins, Michael Hallek
Blood (2022) Vol. 140, Iss. 3, pp. 236-252
Open Access | Times Cited: 108
Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects
Zhan Zhang, Qi Shen, Haocai Chang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 55
Zhan Zhang, Qi Shen, Haocai Chang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 55
Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review
Jingjing Lv, Hui Wu, Junjie Xu, et al.
Infectious Diseases of Poverty (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 33
Jingjing Lv, Hui Wu, Junjie Xu, et al.
Infectious Diseases of Poverty (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 33
RBD-specific antibody responses after two doses of BBIBP-CorV (Sinopharm, Beijing CNBG) vaccine
Tamás Ferenci, Balázs Sarkadi
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 31
Tamás Ferenci, Balázs Sarkadi
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 31
Efficacy and Safety Profile of COVID-19 Vaccine in Cancer Patients: A Prospective, Multicenter Cohort Study
Ayşe İrem Yasin, Sabin Göktaş Aydın, Bilge Sümbül, et al.
Future Oncology (2022) Vol. 18, Iss. 10, pp. 1235-1244
Open Access | Times Cited: 30
Ayşe İrem Yasin, Sabin Göktaş Aydın, Bilge Sümbül, et al.
Future Oncology (2022) Vol. 18, Iss. 10, pp. 1235-1244
Open Access | Times Cited: 30
COVID-19 Vaccination in Patients With Malignancy; A Systematic Review and Meta-Analysis of the Efficacy and Safety
Seyed Alireza Javadinia, Kimia Alizadeh, Mohammad-Shafi Mojadadi, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 29
Seyed Alireza Javadinia, Kimia Alizadeh, Mohammad-Shafi Mojadadi, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 29
A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome?
Maryam Joudi, Maryam Moradi Binabaj, Pejman Porouhan, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 25
Maryam Joudi, Maryam Moradi Binabaj, Pejman Porouhan, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 25
Vaccination with the Inactivated Vaccine (Sinopharm BBIBP-CorV) Ensures Protection against SARS-CoV-2 Related Disease
Chao Wang, Linyi Chen, Qing‐Bin Lu, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 920-920
Open Access | Times Cited: 24
Chao Wang, Linyi Chen, Qing‐Bin Lu, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 920-920
Open Access | Times Cited: 24
COVID-19 vaccination in cancer patients: a narrative review
Suranjith L. Seneviratne, Pamodh Yasawardene, Widuranga Wijerathne, et al.
Journal of International Medical Research (2022) Vol. 50, Iss. 3
Open Access | Times Cited: 23
Suranjith L. Seneviratne, Pamodh Yasawardene, Widuranga Wijerathne, et al.
Journal of International Medical Research (2022) Vol. 50, Iss. 3
Open Access | Times Cited: 23
Determinants of humoral immune response to SARS-CoV-2 vaccines in solid cancer patients: A systematic review and meta-analysis
Durgesh Wankhede, Sandeep Grover, Paul Hofman
Vaccine (2023) Vol. 41, Iss. 11, pp. 1791-1798
Open Access | Times Cited: 12
Durgesh Wankhede, Sandeep Grover, Paul Hofman
Vaccine (2023) Vol. 41, Iss. 11, pp. 1791-1798
Open Access | Times Cited: 12
Challenges posed by COVID‐19 in cancer patients: A narrative review
Zeinab Mohseni Afshar, Rezvan Hosseinzadeh, Mohammad Barary, et al.
Cancer Medicine (2021) Vol. 11, Iss. 4, pp. 1119-1135
Open Access | Times Cited: 28
Zeinab Mohseni Afshar, Rezvan Hosseinzadeh, Mohammad Barary, et al.
Cancer Medicine (2021) Vol. 11, Iss. 4, pp. 1119-1135
Open Access | Times Cited: 28
Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM)
Paolo Pedrazzoli, Angioletta Lasagna, Irene Cassaniti, et al.
ESMO Open (2023) Vol. 8, Iss. 3, pp. 101215-101215
Open Access | Times Cited: 10
Paolo Pedrazzoli, Angioletta Lasagna, Irene Cassaniti, et al.
ESMO Open (2023) Vol. 8, Iss. 3, pp. 101215-101215
Open Access | Times Cited: 10
Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis
Noppacharn Uaprasert, Palada Pitakkitnukun, Nuanrat Tangcheewinsirikul, et al.
Blood Cancer Journal (2022) Vol. 12, Iss. 12
Open Access | Times Cited: 17
Noppacharn Uaprasert, Palada Pitakkitnukun, Nuanrat Tangcheewinsirikul, et al.
Blood Cancer Journal (2022) Vol. 12, Iss. 12
Open Access | Times Cited: 17
Multicenter Study of Antibody Seroprevalence against COVID-19 in Patients Presenting to Iranian Cancer Centers after One Year of the COVID-19 Pandemic
Seyed Alireza Javadinia, Mona Ariamanesh, Maryam Nabavifard, et al.
Cancer Investigation (2021) Vol. 40, Iss. 2, pp. 115-123
Closed Access | Times Cited: 20
Seyed Alireza Javadinia, Mona Ariamanesh, Maryam Nabavifard, et al.
Cancer Investigation (2021) Vol. 40, Iss. 2, pp. 115-123
Closed Access | Times Cited: 20
A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies
Maryam Noori, Shadi Azizi, Farhan Abbasi Varaki, et al.
International Immunopharmacology (2022) Vol. 110, pp. 109046-109046
Open Access | Times Cited: 14
Maryam Noori, Shadi Azizi, Farhan Abbasi Varaki, et al.
International Immunopharmacology (2022) Vol. 110, pp. 109046-109046
Open Access | Times Cited: 14
Immune response of COVID-19 vaccines in solid cancer patients: A meta-analysis
Tiantian Hua, Rui Fan, Fan Yang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Tiantian Hua, Rui Fan, Fan Yang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Safety and immunogenicity of inactivated SARS-CoV-2 vaccine in high-risk occupational population: a randomized, parallel, controlled clinical trial
Yongliang Feng, Jing Chen, Yao Tian, et al.
Infectious Diseases of Poverty (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 18
Yongliang Feng, Jing Chen, Yao Tian, et al.
Infectious Diseases of Poverty (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 18
Clinical Characteristics and Outcomes of COVID-19 in 1294 New Cancer Patients: Single-Center, Prospective Cohort Study from Iran
Danial Fazilat‐Panah, Hamid Fallah Tafti, Yavar Rajabzadeh, et al.
Cancer Investigation (2022) Vol. 40, Iss. 6, pp. 505-515
Closed Access | Times Cited: 13
Danial Fazilat‐Panah, Hamid Fallah Tafti, Yavar Rajabzadeh, et al.
Cancer Investigation (2022) Vol. 40, Iss. 6, pp. 505-515
Closed Access | Times Cited: 13
COVID-19 vaccination for patients with benign childhood epilepsy with centrotemporal spikes
Xinyu Yang, Lulu Wu, Dandan Zheng, et al.
Epilepsy & Behavior (2022) Vol. 134, pp. 108744-108744
Open Access | Times Cited: 11
Xinyu Yang, Lulu Wu, Dandan Zheng, et al.
Epilepsy & Behavior (2022) Vol. 134, pp. 108744-108744
Open Access | Times Cited: 11
COVID-19 Vaccine Safety Monitoring Studies in Low- and Middle-Income Countries (LMICs)—A Systematic Review of Study Designs and Methods
Malede Mequanent Sisay, Camila Montesinos‐Guevara, Alhadi Khogali Osman, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1035-1035
Open Access | Times Cited: 6
Malede Mequanent Sisay, Camila Montesinos‐Guevara, Alhadi Khogali Osman, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1035-1035
Open Access | Times Cited: 6
Clinical and inflammation marker features of cancer patients with COVID-19: data of Istanbul, Turkey multicenter cancer patients (2020–2022)
Çağlar Ünal, Gülşah Tunçer, Betül Çopur, et al.
Current Medical Research and Opinion (2023) Vol. 39, Iss. 7, pp. 987-996
Closed Access | Times Cited: 5
Çağlar Ünal, Gülşah Tunçer, Betül Çopur, et al.
Current Medical Research and Opinion (2023) Vol. 39, Iss. 7, pp. 987-996
Closed Access | Times Cited: 5
A review of COVID vaccines: success against a moving target
S H Chong, Leah Burn, Mark T. K. Cheng, et al.
British Medical Bulletin (2022) Vol. 144, Iss. 1, pp. 12-44
Open Access | Times Cited: 8
S H Chong, Leah Burn, Mark T. K. Cheng, et al.
British Medical Bulletin (2022) Vol. 144, Iss. 1, pp. 12-44
Open Access | Times Cited: 8
Cancer Patients and the COVID-19 Vaccines: Considerations and Challenges
Muna Almasri, Khalifa Bshesh, Wafa Khan, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5630-5630
Open Access | Times Cited: 8
Muna Almasri, Khalifa Bshesh, Wafa Khan, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5630-5630
Open Access | Times Cited: 8
Seroconversion rate after COVID-19 vaccination in patients with solid cancer: A systematic review and meta-analysis
Juntao Yin, Yangyang Chen, Yang Li, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 7
Juntao Yin, Yangyang Chen, Yang Li, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 7
